Skip to main content

Table 3 Quantification of phosporylated Tau (AT8) Positivity

From: Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

#

Pathological diagnosis

Braak Tau

Braak Amyloid

AT8 positivity (% surface area)

Superior

Medial

Mean

sd

Mean

sd

1

AD

VI

C

3,41

2,82

1,88

0,44

2

AD

VI

C

0,79

0,70

1,07

0,55

3

AD

V

C

1,35

0,38

0,04

0,05

4

AD

V

C

15,36

5,13

4,12

2,52

5

AD

IV

C

6,87

1,02

0,37

0,01

6

AD

IV

C

8,72

1,65

1,97

1,25

   

Mean

6.08

5.50

1.57

1.47

7

HC

II

B

48,65

8,73

29,35

2,62

8

HC

II

C

11,92

1,84

3,43

1,87

9

HC

II

O

0,15

0,18

0,00

0,01

10

HC

II

O

0,01

0,01

11

HC

0

A

0,02

0,02

0,03

0,02

12

HC

0

O

0,01

0,01

0,00

0,00

   

Mean

12.15

21.04

5.50

11.78

  1. Means and standard deviations (sd) of AT8 positivity (% surface area) of four superior and medial pictures per patient. AD Alzheimer’s disease, HC Healthy control